---
layout: page
title: Most Recent Publications
cover-img: ["/assets/img/covers/path_autumn.png": "autumn"]
---

### 2022

- KMT2C is a Potential Biomarker of Anti-PD-1 Treatment Response in Metastatic Melanoma. [PMID: 35345335](https://pubmed.ncbi.nlm.nih.gov/35345335/)

- Comprehensive Analysis of Chromatin Accessibility and Transcriptional Landscape Identified BRCA1 Repression as a Potential Pathological Factor for Keloid. [PMID: 36015648](https://pubmed.ncbi.nlm.nih.gov/36015648/)

### 2021

- Identifying the biomarkers and pathways associated with hepatocellular carcinoma based on an integrated analysis approach. [PMID: 34033190](https://pubmed.ncbi.nlm.nih.gov/34033190/)

### 2020

- Screening novel drug candidates for Alzheimer's disease by an integrated network and transcriptome analysis. [PMID: 32516365](https://pubmed.ncbi.nlm.nih.gov/32516365/)

- Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive Disorder. [PMID: 32256400](https://pubmed.ncbi.nlm.nih.gov/32256400/)

- Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers. [PMID: 32412047](https://pubmed.ncbi.nlm.nih.gov/32412047/)

### 2018

- Functional divergence analysis of vertebrate neuronal nicotinic acetylcholine receptor subunits. [PMID: 30044167](https://pubmed.ncbi.nlm.nih.gov/30044167/)

